Literature DB >> 7131180

Limited joint mobility in diabetes mellitus of childhood: natural history and relationship to growth impairment.

A L Rosenbloom, J H Silverstein, D C Lezotte, W J Riley, N K Maclaren.   

Abstract

We report a prospective study of the recently recognized complication of limited joint mobility in childhood diabetes, summarizing data collected over the seven years after the initial description of this sign. Of 309 patients, ranging in age from 1 to 28 years, 30% had limited joint mobility. No race or sex influence on expression of limited joint mobility was found; its appearance was temporally more influenced by age than by duration of diabetes. Of 142 patients with diabetes onset before puberty and of longer than three years' duration, 74 had limited joint mobility. Disproportionate distribution of height percentiles for age characterized this entire group, but those with limited joint mobility had four times the skewing of those without (74 vs 37% below the twenty-fifth percentile). The presence or absence of thyroid microsome or islet cell antibodies did not relate significantly to limited joint mobility. Diabetes control, assessed subjectively by clinical estimation and objectively by hemoglobin A1 levels, was generally unrelated to the joint findings. For patients with diabetes duration less than five years, there was a significant association between hemoglobin A1 and limited joint mobility, but the variability in values explained by this association was small (11%).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131180     DOI: 10.1016/s0022-3476(82)80351-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Risk assessment of the diabetic foot and wound.

Authors:  Stephanie Wu; David G Armstrong
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

2.  Geometric influence of the sagittal and vertical apical base relationship on the ANB angle.

Authors:  Reza Sadat-Khonsari; Henning Dathe; Michael Knösel; Wolfram Hahn; Dietmar Kubein-Meesenburg; Oskar Bauss
Journal:  J Orofac Orthop       Date:  2009-03-26       Impact factor: 1.938

3.  Risk factors for expression and progression of limited joint mobility in insulin-dependent childhood diabetes.

Authors:  J Vuković; M Dumić; A Radica; B Filipović-Grcić; V Jovanović
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

4.  Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study.

Authors:  R Amin; T K Bahu; B Widmer; R N Dalton; D B Dunger
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

Review 5.  Limited joint mobility in insulin dependent childhood diabetes.

Authors:  A L Rosenbloom
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

6.  Limited joint mobility in children and adolescents with insulin dependent diabetes mellitus.

Authors:  C F Clarke; A T Piesowicz; G S Spathis
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

7.  Limited joint mobility and diabetic retinopathy demonstrated by fluorescein angiography.

Authors:  A L Rosenbloom; J I Malone; J Yucha; T C Van Cader
Journal:  Eur J Pediatr       Date:  1984-01       Impact factor: 3.183

8.  A study of the respiratory function in insulin-dependent diabetic patients with and without limited joint mobility (LJM).

Authors:  M Vera; R Suffos; M Carriles; R Güell; N Picasso; M C Alvarez
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

9.  Prevalence of hand disorders in type 2 diabetes mellitus and its correlation with microvascular complications.

Authors:  A Pandey; K Usman; H Reddy; M Gutch; N Jain; Sa Qidwai
Journal:  Ann Med Health Sci Res       Date:  2013-07

10.  Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study.

Authors:  Javier Labad; Antoni Rozadilla; Paula Garcia-Sancho; Joan M Nolla; Eduard Montanya
Journal:  Int J Endocrinol       Date:  2018-05-02       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.